A Lawrence Kenyon

Affiliations

  • Chief Financial Officer at Outlook Therapeutics Inc. (OTLK), 2024-09-30
  • Chief Financial Officer at Arno Therapeutics Inc (ARNI), 2014-02-27
  • President, Ceo And Cfo at Tamir Biotechnology Inc. (ACEL), 2012-07-25
  • Other at Par Pharmaceutical Companies Inc. (PRX), 2010-08-04
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
OTLK $5.69 5,000 $28,446.00 5,946 2024-09-26 Filing
OTLK $1.83 10,000 $18,300.00 18,926 2021-04-20 Filing
OTLK $0.90 25,000 $22,380.00 82,213 2019-02-07 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
OTLK $1.70 1,350 $2,295.00 8,926 2019-09-18 Filing
OTLK $1.70 1,350 $2,295.00 80,863 2019-09-18 Filing
ONS $0.87 10,100 $8,807.20 57,213 2018-09-18 Filing
ONS $1.13 26,165 $29,566.45 67,313 2017-12-22 Filing
PRX $25.27 200 $5,054.00 20,649 2010-03-03 Filing